Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Giada Bianchi

Showing results (1-10 of 96) with videos related to

Pageof 10
Sort By:
Blood|December 5, 2024
Moving forward in good KarMMa in myelomaGiada Bianchi
Blood|January 27, 2022
Sustained minimal residual disease in myelomaGiada Bianchi
Hematology/Oncology Clinics of North America|October 25, 2020
Systemic Amyloidosis Due to Clonal Plasma Cell DiseasesGiada Bianchi, Shaji Kumar
Human Vaccines & Immunotherapeutics|July 8, 2026
Elranatamab: A novel B-cell maturation T-cell engagerShahrier Hossain, Giada Bianchi
British Journal of Haematology|May 29, 2019
Towards a better understanding of monoclonal gammopathy of renal significanceGiada Bianchi, Paul G Richardson
Leukemia & Lymphoma|August 18, 2012
Molecular mechanisms of effectiveness of novel therapies in multiple myelomaGiada Bianchi, Irene M Ghobrial
Cancer Journal (Sudbury, Mass.)|January 30, 2019
Contribution of Inhibition of Protein Catabolism in MyelomaGiada Bianchi, Kenneth C Anderson
Hematology/Oncology Clinics of North America|April 3, 2012
Does my patient with a serum monoclonal spike have multiple myeloma?Giada Bianchi, Irene M Ghobrial
Current Gastroenterology Reports|January 27, 2018
Heavy Chain Disease of the Small BowelGiada Bianchi, Aliyah R Sohani
Current Cancer Therapy Reviews|February 24, 2015
Biological and Clinical Implications of Clonal Heterogeneity and Clonal Evolution in Multiple MyelomaGiada Bianchi, Irene M Ghobrial
Pageof 10

Showing results (1-10 of 96) with videos related to

Sort By:
Pageof 10
Blood|December 5, 2024
Moving forward in good KarMMa in myelomaGiada Bianchi
Blood|January 27, 2022
Sustained minimal residual disease in myelomaGiada Bianchi
Hematology/Oncology Clinics of North America|October 25, 2020
Systemic Amyloidosis Due to Clonal Plasma Cell DiseasesGiada Bianchi, Shaji Kumar
Human Vaccines & Immunotherapeutics|July 8, 2026
Elranatamab: A novel B-cell maturation T-cell engagerShahrier Hossain, Giada Bianchi
British Journal of Haematology|May 29, 2019
Towards a better understanding of monoclonal gammopathy of renal significanceGiada Bianchi, Paul G Richardson
Leukemia & Lymphoma|August 18, 2012
Molecular mechanisms of effectiveness of novel therapies in multiple myelomaGiada Bianchi, Irene M Ghobrial
Cancer Journal (Sudbury, Mass.)|January 30, 2019
Contribution of Inhibition of Protein Catabolism in MyelomaGiada Bianchi, Kenneth C Anderson
Hematology/Oncology Clinics of North America|April 3, 2012
Does my patient with a serum monoclonal spike have multiple myeloma?Giada Bianchi, Irene M Ghobrial
Current Gastroenterology Reports|January 27, 2018
Heavy Chain Disease of the Small BowelGiada Bianchi, Aliyah R Sohani
Current Cancer Therapy Reviews|February 24, 2015
Biological and Clinical Implications of Clonal Heterogeneity and Clonal Evolution in Multiple MyelomaGiada Bianchi, Irene M Ghobrial
Pageof 10